“…Furthermore, the impaired lineage specification and increased cell apoptosis in the ICM of the HBO-exposed blastocysts may contribute to the reduced fetal weights and multiple congenital malformations observed in previous studies involving pregnant rabbits, mice, and Fischer rats exposed to HBO at pressures exceeding 2 ATA. 17,[95][96][97] The use of HBOT in pregnant women is limited due to potential risks such as fetal weight decrease and congenital malformations. 15,17,96 However, there are potential benefits of HBOT in treating certain conditions during pregnancy, including threatened abortion, fetal hypoxia, toxemias of pregnancy, late gestation, diabetes, heart disease, CO intoxication, air embolism, and status epilepticus.…”